CN Stock MarketDetailed Quotes

Zhuhai Rundu Pharmaceutical (002923)

Watchlist
  • 13.95
  • +0.91+6.98%
Market Closed Jan 16 15:00 CST
4.67BMarket Cap-90.00P/E (TTM)

Zhuhai Rundu Pharmaceutical (002923) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation307.92M56.18%
Raw material medicine223.54M40.79%
Intermediate10.02M1.83%
Other business6.59M1.20%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Chemical preparation manufacture307.92M56.18%
Raw material medicine manufacture233.56M42.61%
Other business6.59M1.20%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region148.9M27.17%
South China region121.02M22.08%
Central China80.38M14.67%
Export sales69.87M12.75%
Southwest region61.07M11.14%
North China region39.76M7.25%
Northwest region19.38M3.54%
Northeast region7.69M1.40%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More